NexImmune, Inc. financial statements
NexImmune, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2023
| Revenue | USD 0 | EODHD |
| Net income | −USD 32.34M | EODHD |
| Cash and equivalents | USD 3.2M | EODHD |
| Total debt | USD 68.81K | EODHD |